Ajda T. Rowshani

Emergence of a CD4+CD28− Granzyme B+, Cytomegalovirus-Specific T Cell Subset after Recovery of Primary Cytomegalovirus Infection

Ester M. M. van Leeuwen, Ester B. M. Remmerswaal, Mireille T. M. Vossen et al. · The Journal of Immunology · 2004 · 363 citations

Life Sciences, Immunology, Microbiology +14

AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients

Eduard M. Scholten, Serge C.L.M. Cremers, Rik C. Schoemaker et al. · Kidney International · 2005 · 169 citations · Full text

Medicine, Clinical Pharmacokinetics, Nephrology +16

A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype‐Based With Body‐Weight‐Based Tacrolimus Dosing After Living Donor Kidney Transplantation

Nauras Shuker, Rachida Bouamar, Ron H. N. van Schaik et al. · American Journal of Transplantation · 2015 · 168 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

CD103 Is a Marker for Alloantigen-Induced Regulatory CD8+ T Cells

Elena Uss, Ajda T. Rowshani, Berend Hooibrink et al. · The Journal of Immunology · 2006 · 164 citations

Life Sciences, Cell Biology, Immunology +12

Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial

William H. Marks, Nizam Mamode, Robert A. Montgomery et al. · American Journal of Transplantation · 2019 · 146 citations · Full text

Life Sciences, Immunology, Surgery +17